Taking apart Rap1

Abstract

Mammalian Rap1, a TRF2-interacting protein in the telomeric shelterin complex, was recently shown to repress homology-directed repair at chromosome ends. In addition, Rap1 plays a role in transcriptional regulation and NFkB signaling. Rap1 is unique among the components of shelterin in that it is conserved in budding yeast and has non-telomeric functions. Comparison of mammalian Rap1 to the Rap1 proteins of several budding yeasts and fission yeast reveal both striking similarities and notable differences. The protean nature of Rap1 is best understood by viewing it as an adaptor that can mediate a variety of protein-protein and protein-DNA interactions depending on the organism and the complex in which it is functioning.

Rap1 in Mammals, Yeast and Protozoa

Initially identified in a two-hybrid screen with the shelterin protein TRF2,1 mammalian Rap1 was found to be a distant ortholog of Saccharomyces cerevisiae Rap1 (Fig. 1). Although the sequence conservation is extremely low (too low for a simple BLAST search; reviewed in ref. 1), the two Rap1 proteins have a similar domain structure featuring a single N-terminal BRCT domain, a central region with homology to the Myb DNA binding domain and a C-terminal Rap1-specific protein-interaction domain (RCT domain). However, unlike budding yeast Rap1, which recognizes telomeric DNA directly through the cooperation of its Myb domain with a second motif that forms a Myb-like fold,2,3 mammalian Rap1 associates with telomeres solely through its interaction with TRF2.1 The Myb domain of mammalian Rap1 is not suited for DNA binding because its surface lacks positive charge and therefore is more likely to bind to a protein.4 The telomeric binding of Rap1 is mediated by the association of its C-terminus with a region in the middle of TRF2,1,5 forming a stable 1:1 complex that can be isolated from human cells.6–9 The targets of the Rap1 BRCT domain are not known. BRCT domains often occur in pairs and can function as a phosphopeptide binding module10 but Rap1 has only a single BRCT motif. The Rap1 proteins of fission yeast and trypanosomes are similar to mammalian Rap1 in that they rely on an interaction with a TRF2-like partner to bind to telomeres11–13 (Fig. 1).

It has been speculated that the telomeric DNA binding activity is a specialized feature of budding yeast Rap1 proteins that co-evolved with a change in the telomeric sequence.1,14,15 According to this proposal, the budding yeast ancestor started out with TTAGGG repeat telomeres and a Rap1 bound to a TRF2-like telomeric protein. A change in the telomerase RNA gene would have resulted in an altered telomeric sequence and the new telomeric sequence, the present-day TG_1–3 repeats, would have been rendered functional by the ability of Rap1 to bind to this sequence. The TRF2-like module, now useless at the altered telomeres, is thought to have evolved into the budding yeast transcription factor Tbf1, a TRF-like TTA GGG binding protein.16–20 Consistent with this view, present day yeast still tolerates an artificial telomere composed of TTAGGG repeats even though Rap1 does not bind this sequence.21–23

Mammalian Rap1 Represses HDR at Telomeres but not NHEJ

A crucial question in telomere biology is how the natural ends of chromosomes avoid double strand break (DSB) repair (reviewed in ref. 24). The major DSB repair pathways non-homologous end joining (NHEJ) and homology-directed repair (HDR) must be repressed at chromosome ends to avoid ruinous consequences. NHEJ results in dicentric chromosomes that are unstable in mitosis and can initiate breakage-fusion-bridge (BFB) cycles. HDR can give rise to unequal exchanges between sister telomeres and thus be deleterious to the daughter cell that inherits a shortened telomere (Fig. 2). Furthermore, telomeric HDR, in the form of Break-Induced Replication (BIR) is the basis of a telomerase-independent telomere maintenance mechanism that can lead to immortalization (Fig. 2).25 As this so-called ALT (Alternative Lengthening of Telomeres) pathway is observed in a subset of human cancers (reviewed in ref. 26), it is imperative to understand how HDR is normally repressed at telomeres.

The repression of DSB repair is a key function of shelterin, which, in addition to TRF2 and Rap1 contains TRF1, TIN2, TPP1 and one or two POT1 proteins (POT1a and POT1b in the mouse, POT1 in human) (Fig. 1). NHEJ is primarily repressed by TRF2, although after DNA replication, POT1 helps to prevent telomere fusions as well.27–30 The main model for how TRF2 represses NHEJ invokes the t-loop, a lariat structure formed through strand-invasion of the 3′ telomeric overhang into the duplex part of the telomeric repeat array.24,31,32 In the t-loop configuration, the chromosome end is proposed to be inaccessible to the Ku70/80 heterodimer, which is a ring-shaped complex that initiates NHEJ by loading onto open DNA ends.33

Shelterin also contributes to the repression of HDR at telomeres. Exchanges between sister telomeres (T-SCEs), which can be detected by Chromosome Orientation Fluorescent In Situ Hybridization (CO-FISH34), are prominent after deletion of either TRF2 or both POT1 proteins but only when cells also lack Ku70/80.33,35 When Ku70/80 is present, T-SCEs are rare, even when NHEJ is not taking place (e.g., after removal of POT1a/b30,35), making it difficult to determine the significance of induced recombination events.

Since deletion of TRF2 also removes Rap1 from telomeres (but not the other shelterin components), the question remained as to what extent the TRF2-mediated repression of NHEJ and HDR at telomeres is due to the TRF2-dependent recruitment of Rap1. The contribution of Rap1 to the protection of mammalian telomeres recently emerged from two independent approaches—conditional deletion of the Rap1 gene from mouse embryo fibroblasts (MEFs) and complementation of conditional TRF2 knockout MEFs with a TRF2 mutant (TRF2^ΔRap1) that cannot bind Rap1.5 In both cases, MEFs lacking Rap1 at their telomeres proliferate similarly to wild type MEFs. Furthermore, mice without a functional Rap1 gene (Rap1^Δex2/Δex2) are alive and fertile, establishing that removal of Rap1 from telomeres does not affect organismal viability. The expression level and telomere localization of all other shelterin components is not significantly affected by Rap1 loss. Similarly, Martinez et al.36 reported on a conditional knockout of Rap1 that shows no cellular growth defect or changes in other shelterin components.

The Rap1-deficient cells demonstrated that Rap1 is not required to protect chromosome ends from NHEJ. No telomere fusions were observed when Rap1 was removed from telomeres either through gene deletion or using TRF2^ΔRap1.5,36 This result was unexpected since Rap1 had been implicated in the repression of in vitro NHEJ of telomeric oligos and Rap1 artificially tethered to telomeres was able to inhibit fusions induced by a dominant negative allele of TRF2.37–39 Perhaps Rap1 has an intrinsic ability to block fusions under those conditions but is not required for the protection against NHEJ in vivo.

In contrast, Rap1 is critical for the repression of HDR.5 CO-FISH showed the expected basal level of 2–3% T-SCE per chromosome end in wild type MEFs and in cells lacking either Rap1 or Ku70. However, when Rap1 is deleted from Rap1^F/FKu70^-/- MEFs, the frequency of T-SCEs increased to 10–12% per chromosome end. Similarly, T-SCEs were induced to 8–10% when TRF2^F/FKu70^-/- cells were complemented with the TRF2^ΔRap1 allele and the endogenous TRF2 was deleted. Martinez et al. also noted T-SCEs in Rap1 null cells but the levels are very low (1%), most likely because Ku70/80 was present.36

The frequency of T-SCEs in Ku70 null cells lacking Rap1 at their telomeres is significant when considered in the context of the various resolution pathways of HDR events (reviewed in ref. 40). T-SCEs only occur when the double Holliday junction (dHJ) intermediate is cleaved by resolvases (Mus81/Eme1 or Gen1) in such a way that there is a crossover. However, these resolvases can also resolve dHJs without a crossover and in addition, dHJs can be dissolved by BLM/Top3α (reviewed in ref. 41). When there is no crossover, the HDR event is undetectable by CO-FISH. In light of the various potential outcomes of a recombination event between sister telomeres, the induction of T-SCEs at 10% of the Rap1-deficient telomeres in Ku70^-/- MEFs is highly significant. A similar level of T-SCEs is seen in Ku-deficient cells lacking either TRF2 or both POT1 proteins.33,35

Rap1/Ku70 double null cells provide a unique setting to study HDR independent of DNA damage signaling. In wild type cells, activation of the ATM and ATR kinases at chromosome ends is prevented by TRF2 and POT1a/b, respectively. Rap1 appears to play a minimal (or no) role in the repression of the DNA damage response.5 In Rap1 or Rap1/Ku70 double knockout cells, there is no significant activation of the Chk1 and Chk2 effector kinases and the telomeres do not show the typical accumulation of DNA damage response factors observed when either TRF2 or POT1a/b are deleted.28–30,42 Together with the absence of telomere fusions, this continued repression of the DNA damage signal at telomeres explains why Rap1 deletion is compatible with cellular and organismal viability.5,36,43 In contrast, an increase in HDR at telomeres may not have immediate effects on the viability of a cell population.

The Mechanism of HDR Repression at MammalianTelomeres

How Rap1 represses HDR is not clear. Most likely, it functions by recruiting another protein with either its BRCT domain or the Myb motif. Rap1 interacts with the Rad50 and Mre11 components of the MRN complex, which localizes to DSBs and contributes to the 5′ resection during HDR.6 However, the telomeric overhang is not altered when Rap1 is deleted from Ku70^-/- MEFs, suggesting Rap1 does not play a major role in modulating resection at telomeres. The Rap1/TRF2 complex also interacts with SLX4,40 a scaffold protein that binds to a HJ resolvase (Mus81/Eme1), nucleases (XPF/ERCC1, SLX1) and mismatch repair proteins (Msh2/3). Although it is unclear whether this interaction is relevant, a potential Rap1-SLX4 link raises the possibility that Rap1 interrupts HDR through employing one of the nucleases in the SLX4 complex.

The repression of HDR by shelterin also requires the presence of either of the two POT1 proteins.35 As the POT1 proteins bind to the single-stranded telomeric DNA, it is tempting to invoke their ability to interact with the TTAGGG repeats as the mechanism by which they block HDR. For instance, the POT1 proteins might prevent binding of RPA to single-stranded DNA or interfere with the loading of Rad51. Indeed, POT1a and POT1b appear equivalent in their DNA binding activity and seem equally proficient in the repression of HDR.35 However, POT1a and POT1b are distinct in other aspects of telomere function. Importantly, POT1a is better able to repress the accumulation of detectable RPA foci at telomeres and is a stronger repressor of ATR signaling than POT1b.29,35,42,44 On the other hand, POT1b, but not POT1a, can prevent the formation of inappropriately long 3′ overhangs at the telomere termini.29,35,45,46 This would suggest that POT1a and POT1b may each prevent HDR in a different way, POT1a by repressing RPA binding and POT1b by keeping overhang length in check. Perhaps HDR in the Ku-deficient POT1a/b DKO setting is unleashed because the 3′ overhang is excessively long (due to absence of POT1b) and can readily recruit RPA and Rad51 (because POT1a is absent). In this context, Rap1, which remains at the telomeres, is clearly incapable of repressing HDR. Conversely, when Rap1 is deleted from Ku70-deficient cells, the presence of POT1a and POT1b is insufficient to prevent recombination. This raises the intriguing possibility that Rap1 and the POT1 proteins need to cooperate to form a barrier to the initiation of HDR.

How Ku70/80 represses recombination at telomeres also remains to be determined. Ku70/80 appears to have a general ability to repress HDR at DSBs.47–49 The repression of HDR at telomeres by Ku70/80 is not simply due to promoting the competing NHEJ reaction and thereby depleting the number of chromosome ends available for HDR. This conclusion emerged from the fact that deletion of DNA ligase IV, the main ligase in the NHEJ pathway does not induce HDR at the unfused telomeres.33 A similar but more acute effect of Ku70/80 loss on HDR at telomeres has been reported for human telomeres, which undergo lethal intra-telomeric HDR events when Ku70/80 are deleted but remain intact without DNA ligase IV.48,50 An additional question is whether Ku70/80 has to be associated with telomeres to repress HDR. Ku70/80 has been found at human telomeres by ChIP and PICh51,52 and was shown to interact with TRF1, TRF2 and Rap1.6,53,54 However, the latter two interactions are unlikely to be relevant since deletion of TRF2 or Rap1 alone (thus removing any Ku70/80 that is bound to telomeres through TRF2/Rap1) does not induce T-SCEs. The interaction with TRF1 merits further examination but it is also possible that general nuclear Ku70/80 can repress HDR at telomeres as it does at DSBs.

Non-telomeric Functions of Mammalian Rap1

Although shelterin components principally function at telomeres, Rap1 also has non-telomeric functions36,43 (Fig. 3). Martinez et al. identified a distinct set of genes, including subtelomeric genes, that were significantly upregulated in Rap1-deficient cells, suggesting a role for Rap1 in transcriptional regulation.36 Based on ChIP-sequencing, Rap1 appears to associate with loci that contain at least two TTAGGG repeats.36 It is therefore likely that Rap1 binds to these sites via TRF2. TRF2, like TRF1, binds as a dimer, recognizing two TAG GG core sites with its Myb domains.55,56 Indeed, TRF2 was also enriched at several of the Rap1 binding sites but it is not excluded that Rap1 has additional partners that mediate DNA binding.36

Teo et al. reported an unanticipated role for cytoplasmic Rap1 in the modulation of NFκB signaling.43 Rap1 was identified in a gain-of-function screen for positive regulators of the NFκB signaling pathway. Rap1 is associated with IκB kinases (IKKs), which are responsible for the phosphorylation and subsequent degradation of inhibitors of NFκB (IκB proteins). Thus, Rap1 interacts with the IKKs to activate NFκB-dependent gene expression perhaps directing IKK activity specifically to p65, an inhibitory subunit of NFκB. Consistent with a role for Rap1 outside the nucleus, human cells (but not mouse fibroblasts) contain a considerable fraction of Rap1 in the cytoplasm where it is not associated with TRF2.7 Perhaps it is this fraction that functions with the IKKs. However, in both human and mouse cells, Rap1 protein levels diminish precipitously when it is not associated with TRF2.5,7,28 The presence of an IKK-bound fraction of Rap1 that depends on TRF2 for its expression can be reconciled if Rap1 shuttles between the nucleus and cytoplasm, constantly requiring its interaction with TRF2 for stability. This shuttling hypothesis predicts that TRF2 loss would repress NFκB signaling as a result of Rap1 depletion. Alternatively, there may be a minor TRF2-independent fraction of Rap1 that is sufficient for its role as an IKK partner.

The More Things Change, the More they Stay the Same

Rap1 has been studied in detail in several budding yeasts (Saccharomyces cerevisiae, Kluyveromyces lactis and Candida albicans), the fission yeast Schizosaccharomyces pombe and in the trypanosome protozoan Trypanosoma brucei. In terms of telomere binding, mammalian Rap1 resembles the Rap1 proteins of fission yeast and trypanosomes, which also use a TRF2-like partner (Fig. 1). All Rap1 proteins analyzed in the budding yeasts bind to telomeric DNA directly and C. albicans Rap1 even lacks the RCT domain that targets mammalian Rap1 to telomeres.14 Despite this structural difference, mammalian Rap1 is functionally more similar to the Rap1s of C. albicans and K. lactis, which both repress telomere recombination.14,57 In contrast, Rap1 in S. cerevisiae and S. pombe repress NHEJ and inappropriate resection at telomeres.58–62 Despite these rather extensive variations in structure and function, all Rap1 proteins studied in this regard, including human Rap1, affect telomere length (reviewed in ref. 63 and 64). Furthermore, transcriptional silencing at telomeres may be a general feature of the Rap1 proteins12,36,65–71 whereas transcriptional regulation at non-telomeric loci is a specific feature of the Rap1 proteins of S. cerevisiae and its close relatives.13,14,20,72–76

Rap1 as an Adaptor Protein

The work on mammalian Rap1 and the information on the Rap1 proteins of unicellular organisms indicate that Rap1 is functionally remarkably versatile. In mammalian cells it has at least three distinct functions, one at telomeres, one in NFκB signaling, and one (as yet poorly understood) in transcriptional regulation. Some of the unicellular Rap1 proteins share functions with mammalian Rap1 (repression of HDR at telomeres, gene regulation), but also show capabilities (repression of NHEJ, 5′ end resection) not observed in mammals. Furthermore, Rap1 can either bind DNA directly or do so through interaction with a DNA binding protein.

The easiest way to understand how mammalian Rap1 can fulfill such disparate roles is to view this protein as an adaptor composed of several protein-protein (or protein-DNA) interaction modules. The RCT, Myb and BRCT domains of mammalian Rap1 could each potentially function as a protein interaction domain. If one or more of these domains has multiple partners, it can easily be understood how Rap1 could function in very different complexes in one organism (Fig. 3). For instance, in mammalian cells, shelterin and the putative transcriptional regulatory complexes would contain TRF2 bound to the Rap1 RCT, thereby directing Rap1 to telomeres and [TTAGGG]2-containing gene regulatory sequences where the BRCT and/or Myb domains may have distinct partners (X and Y in Fig. 3) that regulate HDR and gene expression, respectively. In the third complex, Rap1 is not associated with TRF2 but interacts with IKK and perhaps an additional partner that allows Rap1 to direct IKK to IκB (Fig. 3).

The adaptor view of Rap1 can also explain the changes in Rap1 function during evolution (Fig. 3). Switching the interacting partner of the RCT domain of Rap1, for instance, could allow Rap1 to inhibit HDR at telomeres of one organism whereas it blocks NHEJ in another. Indeed, S. cerevisiae Rap1 blocks NHEJ through an interaction of its RCT with Sir4 and Rif2, a protein not present in K. lactis.59 Future efforts to elucidate the interacting partners of Rap1 in K. lactis, C. albicans, S. pombe, mammals and trypanosomes should provide insight into how Rap1 evolved to mediate different processes.

Figures and Tables

Figure 1 Mammalian Rap1 resembles yeast and trypanosome Rap1. Top: The mammalian shelterin complex and its role in repressing HDR at chromosome ends. Bottom: Schematic representation of the conserved protein motifs of Rap1 and its TRF2-like partners in the indicated organisms. MYB indicates regions with a MYB sequence. Myb-fold indicates a motif that lacks sequence similarity to the MYB sequence but has a similar fold. The cyan boxes in Rap1 of S. pombe and T. brucei indicate that while these proteins have sequence similarity to the Myb-fold of S. cerevisiae, their structure has not been determined. It is not known whether Rap1 of S. pombe and T. brucei have an RCT domain but the C-terminus of T. brucei Rap1 is not required for its interaction with its TRF interacting partner.

Figure 2 Outcomes of homology-directed repair at the telomere. Schematics illustrating an innocuous crossover event (top), a deleterious unequal exchange of telomeric DNA (middle) and Break-induced Replication (bottom).

Figure 3 Rap1 as an adaptor protein in mammals and yeast. See text for details.

Acknowledgements

We apologize to the authors whose work on Rap1 we were unable to cite due to space limitations. We thank the members of the de Lange lab for comments. The work on telomeres in our laboratory is supported by grants from the NIH (GM049046, AG016642 and CA076027). Tdl is a Professor of the American Cancer Society. AS was supported by Susan G. Komen for the Cure. SK was supported by the Cancer Research Institute (Emphasis: Pathway in Tumor Immunology)